Terri Eperjesi

[Terri Eperjesi @Teperjesi]

😡

[Terri Eperjesi @Teperjesi]

@Shem_Infinite 🤣👏

[healthbot @thehealthb0t]

Nothing to see here.

Just graphene oxide responding to frequencies.

This substance is now inside millions of people.

Take a moment to reflect on the implications of that.

[Terri Eperjesi @Teperjesi]

@cmb_wps @Mappy6984 🤣

[Terri Eperjesi @Teperjesi]

@TwistedZen69 @StateDept 🤡😂

[Terri Eperjesi @Teperjesi]

@henrycameron57 @thevivafrei 😞🥺😡

[Terri Eperjesi @Teperjesi]

Clown show

[Valerie Anne Smith @ValerieAnne1970]

Hospitals were ORDERED to pump patients full of toxic Remdesivir instead of safe, cheap IVERMECTIN — even though Fauci KNEW Ivermectin worked from the start.

Why? Because Ivermectin would’ve ended the “emergency,” killed the vaccine money machine, and exposed the entire scam.

They **knowingly murdered** countless Americans for profit.

This wasn’t a mistake.
This was mass murder by protocol.

[La Píldora Roja @LaPildoraRed]

“You’re not virtuous. You’re harmless. You’re like a rabbit. Rabbit isn’t virtuous. It can’t do anything except get eaten. It’s not virtuous. If you’re a monster and you don’t act monstrously, then you’re virtuous. But you also have to be a monster. The hero has to be a monster” – Jordan Peterson

[Crazy Rider Fan 🇨🇦 @bdmolnar]

@GadSaad @CrisCDA2 Nailed it 🎯

[Terri Eperjesi @Teperjesi]

@CyberKitten6 @SecRollins @SecKennedy @USDA @RapidResponse47 @RCamposDuffy @CharlesHurt @GriffJenkins @foxandfriends 😂😂

[Pepe_Le_Mew @mew_pepe64678]

@holonabove Hemp. They crushed it because it's better and more efficient

[Nicolas Hulscher, MPH @NicHulscher]

BREAKING: Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a MAJOR Cancer Journal

84.4% of cancer patients taking ivermectin + mebendazole for 6 months declared either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION.

Our study, “Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,” is now peer-reviewed and published in Anticancer Research—a major international oncology journal of the International Institute of Anticancer Research (IIAR), established in 1995.

The results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.

A diverse population of cancer patients (n=197) was prescribed compounded ivermectin–mebendazole through a U.S. telemedicine platform, with each capsule containing 25 mg ivermectin and 250 mg mebendazole.

Participants were followed for approximately six months using standardized digital surveys assessing cancer outcomes, medication adherence, and tolerability.

At approximately six months post-treatment initiation, we observed an 84.4% Clinical Benefit Ratio (CBR)—meaning more than four out of five patients reported either:
No evidence of disease (32.8%)
Tumor regression (15.6%)
or Cancer stabilization (36.1%)

Importantly, adherence was remarkably high, with 86.9% completing the initial prescription and 66.4% remaining on therapy at six months.

Side effects were predominantly mild and manageable, reported in 25.4% of patients (primarily gastrointestinal), with 93.6% of those experiencing side effects continuing treatment after minor dosing adjustments.

This groundbreaking peer-reviewed publication was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel—uniting real-world clinical data, frontline medical experience, and epidemiologic expertise to evaluate inexpensive, repurposed therapies with major translational potential.

With these extraordinarily promising results, double-blind, placebo-controlled clinical trials are now required.

In the meantime, many cancer patients are exercising their right to try.

@twc_health @McCulloughFund @IIAR_Journals @P_McCulloughMD @DrHarveyRisch @DrKellyVictory @jathorpmfm @drdrew @PeterGillooly @FosterCoulson